Atlanta Gastroenterology Associates has agreed to pay $4.75 million to settle federal civil allegations that it took kickbacks and billed Medicare and other insurers for pathology testing that prosecutors say patients did not always need. The deal, announced Friday, focuses on a relationship with an Arkansas pathology company and the routine use of automatic “special stains” on biopsy samples. The settlement resolves civil claims only and does not include any admission of liability by the practice.
According to a Justice Department press release, federal officials say Atlanta Gastroenterology began working with Little Rock-based Advanced Pathology Solutions (APS) around May 2017 to design and run a limited-capacity pathology lab inside the practice’s offices. Under that arrangement, APS pathologists interpreted slides while the clinic billed for the technical component. Prosecutors allege APS provided benefits tied to building and operating the in-house lab and that Atlanta Gastroenterology agreed to send its specimens to APS exclusively. “This settlement reflects the Department’s commitment to protecting taxpayer money,” Assistant Attorney General Brett A. Shumate said in the announcement. The Justice Department said the relationship wrapped up around May 2020.
As reported by FOX 5 Atlanta, investigators say the clinic used a blanket or “reflex” ordering process that sent out special stains automatically, before a pathologist reviewed the routine stain or documented why the extra test was needed. The local outlet also notes that the settlement closes out civil allegations only and that there has been no court finding of liability.
How prosecutors say the lab setup worked
Government filings describe a division of labor in which histology technicians inside the Atlanta office prepared biopsy slides while APS handled the interpretations elsewhere. Prosecutors say that structure created a financial motive to keep referrals flowing and that the reflex ordering of special stains was one way the arrangement generated extra billable work.
Federal scrutiny of alleged referral kickbacks is not new in Georgia. The Atlanta Journal-Constitution reported a multi-million-dollar radiology kickback settlement in 2024, and WSB-TV covered a $2.18 million false-claims settlement with an Atlanta-area arthritis clinic in January.
Legal implications
In its Justice Department press release, the government said the Atlanta Gastroenterology resolution grew out of a coordinated enforcement push involving DOJ’s Civil Division, the U.S. Attorney’s Office for the Eastern District of Arkansas and inspectors general for HHS, the Department of Defense and the Department of Veterans Affairs. Officials repeated that “the claims resolved by the settlement are allegations only and there has been no determination of liability.” Trial attorneys identified in the announcement led the investigation and negotiated the civil deal.
What patients and local providers should know
Patients who had biopsies or other pathology services through Atlanta Gastroenterology between 2017 and 2020 may want to pull their bills and insurance explanations of benefits and ask the practice or their insurer for an itemized breakdown if anything seems unfamiliar. It is a tedious chore, but it is one of the few ways patients can see what was actually billed in their name.
For local providers, the case is a reminder that arrangements with outside labs need tight documentation and clear medical justification, especially around automatic or reflex test ordering. Civil False Claims Act settlements are designed to claw back money for federal programs, but they also tend to spark closer review of billing patterns by regulators and insurers.
The government’s announcement is the primary source for details on the civil settlement, while FOX 5 Atlanta highlighted key local context and the case timeline. The deal resolves the government’s False Claims Act allegations yet leaves open broader questions about how common reflex staining practices and similar lab partnerships might be across the region.
